Today: 19 July 2026
Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week
15 February 2026
1 min read

Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week

New York, Feb 14, 2026, 19:33 (EST) — The session wrapped with the market shut.

Shares of Procter & Gamble (PG.N) slipped roughly 0.7% Friday, ending the session at $160.07. The stock moved between $159.72 and $162.56, with around 14.0 million shares changing hands.

Wall Street finished up a volatile week on a cautious note, just before the long Presidents Day break that keeps U.S. markets shut Monday. The S&P 500 eked out a 0.05% gain Friday, with the Nasdaq slipping 0.22%, as traders zeroed in on tech heavyweights. “Large cap tech stocks continue to be an anchor on the market,” said Michael James, managing director at Rosenblatt Securities. Reuters

Inflation’s impact kept defensive stocks like P&G in focus, with investors eyeing their usual sensitivity to rate moves, thanks to reliable dividends and cash flow. The Labor Department reported the Consumer Price Index climbed 0.2% in January, missing expectations for a 0.3% increase. Core CPI, which excludes food and energy, ticked up 0.3%. “Price pressures remain a little too hot for comfort,” Edward Jones senior economist James McCann said. Reuters

Italy’s competition watchdog has launched a probe into P&G, zeroing in on Braun Skin i-Expert epilator ads that promise two years without body hair. P&G responded, saying it relies on “a rigorous process in place to verify that all claims are based on proven performance data,” and that it plans to work with the authority. Reuters

Gary A. Coombe, who heads P&G’s Grooming business, exercised options on 36,093 shares and immediately sold those shares at a weighted average price of $162.3307, according to a separate U.S. Form 4 insider trading disclosure. The Feb. 12 transaction left him with roughly 34,994 shares in direct ownership, per the filing.

Cash is heading back to shareholders soon. P&G plans to deliver its next quarterly dividend—$1.0568 per share—on Feb. 17, per its dividend history.

P&G’s most recent major operational update landed on Jan. 22. Second-quarter revenue was a notch below Wall Street forecasts, but adjusted earnings edged past estimates. The company pointed to sluggish U.S. consumer spending and hurdles from a government shutdown. Beauty proved more resilient compared with certain key household lines.

The near term looks messy. Italy’s probe is a cloud that could linger, weighing more than some investors might hope. And if services inflation refuses to budge, rate bets could get jumpy, shaking up those dividend-rich consumer stocks again.

On deck for Thursday, Feb. 19: CEO Shailesh Jejurikar, CFO Andre Schulten, and CIO Seth Cohen are slated to take the stage at 9:00 a.m. ET at the Consumer Analyst Group of New York conference. Not long after, Reckitt Benckiser and Kimberly-Clark step up, offering investors a fast read on how demand and pricing stack up across the sector’s household and personal-care names.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Molina Healthcare: Market Sentiment Misses the Mark
    July 19, 2026, 6:19 AM EDT. The market's reading of Molina Healthcare's valuation appears mistaken, opening a window for investors. An independent finance expert, experienced in macroeconomic analysis, technical patterns, and momentum-driven trading, makes the case that shares are currently undervalued. The analyst's method prioritises capital protection and a favourable risk-reward profile, blending Growth At A Reasonable Price (GARP) with momentum strategies for a balanced investment framework. The article highlights Molina Healthcare's prospects with actionable, data-backed observations in a turbulent market, encouraging investors to reassess the cautious outlook now prevailing.
Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings
Previous Story

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop